Arrowhead Pharmaceuticals said Tuesday that its gene-silencing candidates helped people with obesity lose fat.

Australia’s 2025 flu season lasted weeks longer than it normally does. Hong Kong’s hit so early that the rollout of seasonal ...

Lee Fleisher oversaw the development of the ‘hospital at home’ CMS waiver. Congress must update the program, he writes.

One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

Federal appeals court judges upheld a lower court’s ruling preventing the NIH from cutting billions of dollars in support for ...

WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response ...

David Mitchell, who helped launch Patients for Affordable Drugs to raise awareness of high drug prices and seek to bring them ...

Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per ...

The debate over paying for AI will intensify as more devices enter the field, STAT’s Katie Palmer reports. The FDA has ...

We have plenty of fresh coverage to start the week. We can also report that our upcoming STAT@JPM event — featuring Richard ...

Argenx CEO Tim Van Hauwermeiren is stepping down in May and will be succeeded by Karen Massey, the Belgian drugmaker's COO.

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...